Korea:000220

Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules

* Lined up all the sold Newmacor capsules end-to-end would reach 1,043km * Future target growth is to reach blockbuster levels and exceed 10 billion KRW SEOUL, South Korea, Feb. 10, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) is celebrating the 5th anniversary of the ...

2020-02-10 22:00 401

Yuyu Pharma Unveils New Corporate Logo

SEOUL, South Korea, Sept. 30, 2019 /PRNewswire/ -- Yuyu's corporate logo was first created in 1941 to honor the company's proud history and highlight Yuyu's image as a company on the cutting-edge of the industry.  Yuyu Pharma ...

2019-09-30 21:00 404

Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...

2019-07-17 21:00 1699